Eli Lilly takes actions to stop compounders from making its weight loss med
Eli Lilly (NYSE:LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass compounding ...
Eli Lilly Threatens Obesity Drug Copycat Makers After Shortage
Eli Lilly & Co. is targeting additional drug compounders and telehealth companies that make copycat versions of its weight ...
Novo Nordisk shares post the biggest monthly decline since 2002
Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several ...
Louisville Public Media14h
Midwest state attorneys general call for FDA to clamp down on counterfeit obesity drugs
The attorneys general sent a letter saying the FDA needs to take action because high demand for the weight loss drugs paired with shortages has created a market for counterfeits.